{
    "title": "US FDA approves BioMarin's gene therapy for hemophilia A",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12248369/US-FDA-approves-BioMarins-gene-therapy-hemophilia-A.html",
    "date": "2023-06-29",
    "keywords": [
        "therapy",
        "company",
        "gene",
        "drug",
        "hemophilia",
        "blood",
        "roctavian",
        "treatment",
        "factor",
        "biomarin",
        "warranty",
        "health",
        "year",
        "thursday",
        "approval",
        "protein",
        "viii",
        "market",
        "food",
        "administration",
        "bleeding",
        "disorder",
        "alternative",
        "trial",
        "durability",
        "study",
        "virus",
        "immune",
        "system",
        "dose",
        "cost",
        "patient",
        "reimbursement",
        "replacement",
        "form",
        "way",
        "need",
        "clot",
        "debate",
        "uptake",
        "joel",
        "beatty",
        "research",
        "analyst",
        "baird",
        "companys",
        "facility",
        "california",
        "copy",
        "bloodclotting",
        "slow",
        "onetime",
        "dosing",
        "lot",
        "share",
        "antibody",
        "function",
        "union",
        "brand",
        "name",
        "april",
        "range",
        "khushi",
        "mandowara",
        "bhanvi",
        "satija",
        "sriram",
        "deena",
        "beasley",
        "krishna",
        "chandra",
        "eluri",
        "maju",
        "samuel",
        "david",
        "gregorio"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}